CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 49 filers reported holding CYTOSORBENTS CORP in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $97,000 | -27.1% | 12,150 | -10.0% | 0.04% | -23.2% |
| Q2 2020 | $133,000 | +27.9% | 13,500 | 0.0% | 0.06% | +21.7% |
| Q1 2020 | $104,000 | +100.0% | 13,500 | 0.0% | 0.05% | +142.1% |
| Q4 2019 | $52,000 | -22.4% | 13,500 | 0.0% | 0.02% | -29.6% |
| Q3 2019 | $67,000 | -24.7% | 13,500 | 0.0% | 0.03% | -32.5% |
| Q2 2019 | $89,000 | -16.0% | 13,500 | -4.3% | 0.04% | -42.0% |
| Q1 2019 | $106,000 | -11.7% | 14,108 | -4.0% | 0.07% | +19.0% |
| Q4 2018 | $120,000 | -31.8% | 14,700 | 0.0% | 0.06% | -38.3% |
| Q3 2018 | $176,000 | +40.8% | 14,700 | -16.7% | 0.09% | +64.9% |
| Q2 2018 | $125,000 | -50.0% | 17,650 | -50.0% | 0.06% | -23.0% |
| Q1 2018 | $250,000 | +242.5% | 35,300 | +234.6% | 0.07% | +117.6% |
| Q4 2017 | $73,000 | – | 10,550 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 1,772,000 | $13,379,000 | 1.58% |
| Sargent Investment Group, LLC | 856,315 | $6,465,000 | 1.53% |
| Avenir Corp | 1,366,549 | $10,317,000 | 0.82% |
| CM Management, LLC | 150,000 | $1,133,000 | 0.82% |
| Winning Points Advisors, LLC | 136,900 | $1,035,000 | 0.78% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,397,000 | 0.46% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,847,000 | 0.15% |
| Redmile Group, LLC | 1,304,369 | $9,848,000 | 0.15% |
| Granahan Investment Management | 1,003,546 | $7,577,000 | 0.14% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $265,000 | 0.14% |